Short-term immunotherapy, results of a PMS study;Kurzzeit-immuntherapie - Ergebnisse einer anwendungsbeobachtung

Allergologie

Volumn 25, Issue 8, 2002, Pages

  Drachenberg, K J ^a   Proll S ^a   Urban, E ^a  

^a Bencard Allergie GmbH   (Germany)

Author keywords

Allergoids; Asthma; Conjunctivitis; Efficacy; PMS; Pollen; Rhinitis; Short term immunotherapy; SIT, MPL ; Tolerability

Indexed keywords

ALLERGEN; POLLINEX QUATRO; VACCINE;

ADULT; ARTICLE; ASTHMA; CONJUNCTIVITIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SURVEILLANCE PROGRAM; DRUG TOLERABILITY; DYSPNEA; EDEMA; ERYTHEMA; FEMALE; GRASS; HUMAN; IMMUNITY; IMMUNOTHERAPY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PAIN; PATIENT MONITORING; POLLEN; POSTMARKETING SURVEILLANCE; PRURITUS; RESPIRATORY TRACT ALLERGY; RHINITIS; RHINOCONJUNCTIVITIS; SEASONAL VARIATION; TREATMENT PLANNING; TREE; URTICARIA; VACCINATION;

EID: 0036684836     PISSN: 03445062     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Das management der allergischen rhinitis und ihr einfluß auf das asthma
2. Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration
3. Specific immunotherapy in rhinitis and Asthma
4. Allergen immunotherapy: Therapeutic vaccines for allergic diseases. WHO position paper
5. Tolerance and safety of specific immunotherapy (SIT) with a tyrosine-adsorbed pollen allergoid adjuvanted by monophosphoryl lipid A (MPL®) in children and adolescents
6. A well-tolerated grass-pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections
7. Skin reactivity and immunological profiles during short-term specific immunotherapy (SIT) with a tyrosine-adsorbed pollen allergoid adjuvanted by monophosporyl lipid A (MPL®) in children and adolescents
8. Immonological adjuvants in allergy vaccines: Past, present and future
9. Die spezifische immuntherapie (hyposensibilisierung) mit allergenen. Positions-papier der Deutschen Gesellschaft für Allergologie und Klinische Immunologie
10. Comparison of the efficacy and safety of two preseasonal regimes of glutaraldehyde modified, tyrosine-adsorbed parietria pollen extract over a period of three years in monosensitive patients
11. A Th1inducing adjuvant, MPL®, enhances antibody profiles in experimental animals suggesting it has the potential to improve the efficacy of allergy vaccines